✦ LIBER ✦

New CT response criteria in non-small cell lung cancer: Proposal and application in EGFR tyrosine kinase inhibitor therapy

✍ Scribed by Lee, Ho Yun; Lee, Kyung Soo; Ahn, Myung-Ju; Hwang, Hye Sun; Lee, Ju Won; Park, Keunchil; Ahn, Jin Seok; Kim, Tae Sung; Yi, Chin A; Chung, Myung Jin

Book ID: 119320489
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 819 KB
Volume: 73
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2010.10.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New strategies to overcome limitations o

New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer

✍ Doebele, Robert C.; Oton, Ana B.; Peled, Nir; Camidge, D. Ross; Bunn, Paul A. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 757 KB

EGFR Mutations and EGFR Tyrosine Kinase

EGFR Mutations and EGFR Tyrosine Kinase Inhibition in Non–Small Cell Lung Cancer

✍ Vincent A. Miller 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Activating and resistance mutations of E

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

✍ Gazdar, A F 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 213 KB

Volumetric tumor growth in advanced non-

Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy

✍ Nishino, Mizuki; Dahlberg, Suzanne E.; Cardarella, Stephanie; Jackman, David M.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

9087 POSTER Clinical Responses to EGFR-t

9087 POSTER Clinical Responses to EGFR-tyrosine Kinase Inhibitor Retreatment in Non-small Cell Lung Cancer Patients Who Benefited Prior Gefitinib Therapy

✍ Watanabe, S.; Saida, Y.; Ichikawa, K.; Koshio, J.; Baba, J.; Miura, S.; Tanaka, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

EGFR and KRAS mutations as criteria for

EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer

✍ van Zandwijk, N; Mathy, A; Boerrigter, L; Ruijter, H; Tielen, I; de Jong, D; Baa 📂 Article 📅 2007 🏛 Oxford University Press 🌐 English ⚖ 107 KB